A study reveals how cancer disrupts RNA splicing and presents a potential therapy using antisense oligonucleotides to target ...

A child with a rare genetic disorder — spinal muscular atrophy type I — was treated prenatally for the first time. Courtesy of Jakob Owens  via Unsplash During an amniocentesis test, a long, thin ...

Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different versions of a film.

Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different ...

LncRNAs and circRNAs are key regulators of gene expression, influencing disease mechanisms and offering potential as ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

UCSF scientists find a trove of new targets for cancer immunotherapy in cancer’s unique version of RNA splicing.

Plants survive cold by adjusting at cellular level. Scientists discovered that the PORCUPINE protein helps plants adapt to ...

Spliceosome structures have been investigated extensively in the past decade, but most of the studies have been restricted to ...